The Immediate and Long-term Effects of Prenatal Opioid Exposure

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2022 Nov 24

PMID 36419918

Authors

Elizabeth Yen

Jonathan M Davis

Affiliations

Soon will be listed here.

Abstract

The opioid epidemic has adversely affected neonates and children, yet the mechanisms by which it impacts this population are not well understood. Not only does prenatal opioid exposure result in short-term consequences shortly after birth, it also creates long-term sequelae that may predispose these children to physical, emotional, psychiatric, cognitive, and socioeconomic problems in the future. This article provides a scoping overview of the long-term effects of antenatal opioid exposure on neonates and children as well as quality improvement and research efforts to understand and mitigate this major public health concern.

Citing Articles

Outpatient tapering of buprenorphine in opioid use disorder pregnancies may improve neonatal outcomes.

Shah D, Adelli R, Chroust A, Lewis N, Olsen M J Perinatol. 2025; .

PMID: 39929991 DOI: 10.1038/s41372-025-02211-6.

Maternal exposure to buprenorphine, but not methadone, during pregnancy reduces social play behavior across two generations of offspring.

Nyberg H, Bogen I, Nygaard E, Achterberg M, Andersen J Psychopharmacology (Berl). 2024; 242(3):663-680.

PMID: 39633163 PMC: 11861248. DOI: 10.1007/s00213-024-06718-2.

Prenatal Opioid Exposure and Immune-Related Conditions in Children.

Kelty E, Rae K, Jantzie L, Wyrwoll C, Preen D JAMA Netw Open. 2024; 7(1):e2351933.

PMID: 38231512 PMC: 10794935. DOI: 10.1001/jamanetworkopen.2023.51933.

A Prospective Multi-Institutional Study Comparing the Brain Development in the Third Trimester between Opioid-Exposed and Nonexposed Fetuses Using Advanced Fetal MR Imaging Techniques.

Yun H, Nagaraj U, Grant P, Merhar S, Ou X, Lin W AJNR Am J Neuroradiol. 2024; 45(2):218-223.

PMID: 38216298 PMC: 11285994. DOI: 10.3174/ajnr.A8101.

Neonatal Abstinence Syndrome: An Insight Over Impact of Maternal Substance Use.

Dumbhare O, Taksande A Cureus. 2023; 15(10):e47980.

PMID: 38034154 PMC: 10686242. DOI: 10.7759/cureus.47980.

References

Lembeck A, Tuttle D, Locke R, Lawler L, Jimenez P, Mackley A . Breastfeeding and Formula Selection in Neonatal Abstinence Syndrome. Am J Perinatol. 2020; 38(14):1488-1493. DOI: 10.1055/s-0040-1713754. View

Short V, Gannon M, Abatemarco D . The Association Between Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital Births. Breastfeed Med. 2016; 11:343-9. DOI: 10.1089/bfm.2016.0084. View

Wouldes T, Woodward L . Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months. PLoS One. 2020; 15(10):e0240905. PMC: 7567379. DOI: 10.1371/journal.pone.0240905. View

Loudin S, Haas J, Payne M, Linz M, Meaney-Delman D, Honein M . Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy. J Pediatr. 2019; 217:196-198. PMC: 7503060. DOI: 10.1016/j.jpeds.2019.09.029. View

Dryden C, Young D, Hepburn M, Mactier H . Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG. 2009; 116(5):665-71. DOI: 10.1111/j.1471-0528.2008.02073.x. View

Patrick S, Dudley J, Martin P, Harrell F, Warren M, Hartmann K . Prescription opioid epidemic and infant outcomes. Pediatrics. 2015; 135(5):842-50. PMC: 4411781. DOI: 10.1542/peds.2014-3299. View

Yuan Q, Rubic M, Seah J, Rae C, Wright I, Kaltenbach K . Do maternal opioids reduce neonatal regional brain volumes? A pilot study. J Perinatol. 2014; 34(12):909-13. DOI: 10.1038/jp.2014.111. View

Walhovd K, Bjornebekk A, Haabrekke K, Siqveland T, Slinning K, Nygaard E . Child neuroanatomical, neurocognitive, and visual acuity outcomes with maternal opioid and polysubstance detoxification. Pediatr Neurol. 2015; 52(3):326-32.e1-3. DOI: 10.1016/j.pediatrneurol.2014.11.008. View

Haight S, Ko J, Tong V, Bohm M, Callaghan W . Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018; 67(31):845-849. PMC: 6089335. DOI: 10.15585/mmwr.mm6731a1. View

10.

OConnor A, Kelly B, OBrien L . Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. Drug Alcohol Depend. 2017; 180:200-203. DOI: 10.1016/j.drugalcdep.2017.08.012. View

11.

Choo R, Huestis M, Schroeder J, Shin A, Jones H . Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug Alcohol Depend. 2004; 75(3):253-60. DOI: 10.1016/j.drugalcdep.2004.03.012. View

12.

Monnelly V, Anblagan D, Quigley A, Blesa Cabez M, Cooper E, Mactier H . Prenatal methadone exposure is associated with altered neonatal brain development. Neuroimage Clin. 2018; 18:9-14. PMC: 5760461. DOI: 10.1016/j.nicl.2017.12.033. View

13.

Huybrechts K, Bateman B, Desai R, Hernandez-Diaz S, Rough K, Mogun H . Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. 2017; 358:j3326. PMC: 5538591. DOI: 10.1136/bmj.j3326. View

14.

Velez M, Jansson L . The Opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med. 2009; 2(3):113-20. PMC: 2729936. DOI: 10.1097/ADM.0b013e31817e6105. View

15.

Hwang C, Kang E, Kornegay C, Staffa J, Jones C, McAninch J . Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014. Am J Prev Med. 2016; 51(2):151-160. DOI: 10.1016/j.amepre.2016.02.014. View

16.

Morimoto D, Washio Y, Hatayama K, Okamura T, Watanabe H, Yoshimoto J . Head circumference in infants with nonopiate-induced neonatal abstinence syndrome. CNS Spectr. 2020; 26(5):509-512. DOI: 10.1017/S1092852920001522. View

17.

Alsaleem M, Dusin J, Akangire G . Effect of Low Lactose Formula on the Short-Term Outcomes of Neonatal Abstinence Syndrome: A Systematic Review. Glob Pediatr Health. 2021; 8:2333794X211035258. PMC: 8312188. DOI: 10.1177/2333794X211035258. View

18.

Merhar S, Parikh N, Braimah A, Poindexter B, Tkach J, Kline-Fath B . White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure. AJNR Am J Neuroradiol. 2019; 40(12):2161-2165. PMC: 6911627. DOI: 10.3174/ajnr.A6282. View

19.

Finnegan L, Connaughton Jr J, KRON R, EMICH J . Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975; 2(1-2):141-58. View

20.

Zubler J, Wiggins L, Macias M, Whitaker T, Shaw J, Squires J . Evidence-Informed Milestones for Developmental Surveillance Tools. Pediatrics. 2022; 149(3). PMC: 9680195. DOI: 10.1542/peds.2021-052138. View